# Lessons from the first ecancer symposium on angiogenesis in gastric cancer

## TL;DR

This paper summarizes a 2015 symposium on angiogenesis in gastric cancer, highlighting discussions on biomarkers, imaging, and antiangiogenic drugs.

## Contribution

The paper provides a synthesis of current research and clinical insights on angiogenesis in gastric cancer from expert discussions.

## Key findings

- Experts discussed the role of biomarkers in angiogenesis for gastric cancer.
- Current antiangiogenic drug development and clinical applications were reviewed.
- Interactive sessions emphasized the importance of multidisciplinary approaches in the field.

## Abstract

In March 2015, ecancer hosted a symposium at the European Institute of Oncology in Milan, Italy on the topic of angiogenesis in gastric cancer.

During this meeting, leaders in the field focused on the latest research on the topic of angiogenesis in gastric cancer, delivering lectures combined with interactive question and answer (Q & A) sessions and a roundtable discussion with the meeting’s chairs. Topics covered included biomarkers, imaging, and the current state of antiangiogenic drugs in gastric cancer.

This report will provide an understanding of the relevance of angiogenesis in gastric cancer research, and clinical experiences from diverse perspectives.